Jan Swasthya Abhiyan

Jan Swasthya Abhiyan

People's Health Movement – India

Menu

Skip to content
  • Home
  • About Us
  • Resources
    • Statements
    • Booklets
    • Position papers
    • Useful Documents
  • Thematic Areas
    • Environment and Health
    • Health and Social Justice
    • Gender and Health
    • Child Health
    • Access to Medicines
    • Regulation of Private Sector
    • Privatisation and PPP
    • Public Health Services
  • Contact Us
September 12, 2018 by phmindia_jsa

Prohibition and restriction of manufacture, sale and distribution of Fixed Dose Combinations (FDCs)

This entry was posted in Access to Medicines. Bookmark the permalink.

Post navigation

← Tamil Nadu State Health Assembly to be held on 15th September 2018
A.P. Peoples Health Assembly on 16th September →

State JSAs

Useful Links

  • Global Health Watch
  • People’s Health Movement
  • Photo Gallery
  • JSA in News

Recent Posts

  • Jan Swasthya Abhiyan stands in support of Dr. Saibal Jana and Dr. Dipankar Sengupta (Shaheed Hospital); Demands Withdrawal of Suspension Orders by the Chhattisgarh Medical Council
  • Dr. Amit Sengupta Fellowship on Health Rights 2022
  • JSA statement condemning growing communal violence
  • Implications of the Union Budget 2022-23 for Health – JSA Press Release
  • Safeguarding Prison Health during the ongoing COVID-19 pandemic
Proudly powered by WordPress | Theme: Misty Lake by WordPress.com.